A detailed history of Creegan & Nassoura Financial Group, LLC transactions in Stryker Corp stock. As of the latest transaction made, Creegan & Nassoura Financial Group, LLC holds 2,950 shares of SYK stock, worth $1.14 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
2,950
Previous 2,950 -0.0%
Holding current value
$1.14 Million
Previous $1 Million 6.18%
% of portfolio
0.67%
Previous 0.69%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$293.94 - $358.71 $88,182 - $107,613
-300 Reduced 9.23%
2,950 $1.06 Million
Q4 2023

Feb 14, 2024

SELL
$253.85 - $299.46 $25,385 - $29,945
-100 Reduced 2.99%
3,250 $973,000
Q3 2023

Nov 14, 2023

SELL
$266.54 - $302.43 $26,654 - $30,243
-100 Reduced 2.9%
3,350 $915,000
Q2 2023

Aug 14, 2023

SELL
$271.49 - $305.09 $162,894 - $183,053
-600 Reduced 14.81%
3,450 $1.05 Million
Q1 2023

May 15, 2023

SELL
$246.13 - $285.47 $147,678 - $171,282
-600 Reduced 12.9%
4,050 $1.16 Million
Q4 2022

Feb 14, 2023

SELL
$205.51 - $253.93 $5,137 - $6,348
-25 Reduced 0.53%
4,650 $1.14 Million
Q3 2022

Nov 14, 2022

SELL
$189.27 - $231.83 $94,635 - $115,915
-500 Reduced 9.66%
4,675 $947,000
Q4 2021

Feb 14, 2022

SELL
$236.63 - $276.44 $11,831 - $13,822
-50 Reduced 0.96%
5,175 $1.38 Million
Q3 2021

Nov 15, 2021

SELL
$248.9 - $280.09 $18,667 - $21,006
-75 Reduced 1.42%
5,225 $1.38 Million
Q2 2021

Aug 16, 2021

SELL
$242.95 - $267.0 $60,737 - $66,750
-250 Reduced 4.5%
5,300 $1.38 Million
Q1 2021

May 17, 2021

SELL
$221.01 - $248.82 $156,917 - $176,662
-710 Reduced 11.34%
5,550 $1.35 Million
Q4 2019

Feb 14, 2020

BUY
$197.98 - $220.53 $1.24 Million - $1.38 Million
6,260 New
6,260 $1.31 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $146B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Creegan & Nassoura Financial Group, LLC Portfolio

Follow Creegan & Nassoura Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creegan & Nassoura Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Creegan & Nassoura Financial Group, LLC with notifications on news.